← All indications
Latent Tuberculosis
The dormant form of TUBERCULOSIS where the person shows no obvious symptoms and no sign of the causative agent (Mycobacterium tuberculosis) in the SPUTUM despite being positive for tuberculosis infection skin test.
Drugs by status
Phase 4 trials (8)
Phase 3 trials (4)
Phase 1 trials (4)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (17)
- Aarhus University
- Hospital Virgen de la Luz
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Instituto Nacional de Enfermedades Respiratorias
- Taichung Veterans General Hospital
- University of Copenhagen
- Instituto Nacional de la Nutrición Salvador Zubiran
- Government of Mexico
- National Taiwan University
- Laboratorios Nacionales de Biológicos y Reactrivos
- Instituto Nacional de Ciencias Medicas y Nutricion
- University of Barcelona
- Wellcome Trust
- Bill and Melinda Gates Foundation
- Cellestis
- ChungHwa Veterans house
- Centers for Disease Control and Prevention (CDC)
Organization Involved with Phase 3 Indications (34)
- Serum Institute of India Pvt. Ltd.
- Vakzine Projekt Management GmbH
- Fundación Pública Andaluza
- Medical Research Council
- Chulalongkorn University
- University of London
- Harvard University
- McGill University
- The HIV Netherlands Australia Thailand Research Collaboration
- Universidad Complutense de Madrid
- Fudan University
- University of Cape Town
- University of Colorado, Denver
- Vanderbilt University
- Spanish Network for Research in Infectious Diseases
- Jiao Tong University
- Hatyai Hospital
- HIV-NAT Thai Red Cross AIDS Research Center
- KhonKaen University
- Department of Veteran Affairs
- Chiangrai Prachanukroh Hospital
- Canadian Institutes of Health Research (CIHR)
- Bhumibol Adulyadej Hospital
- Buddhachinaraj Hospital
- Queen Savang Vadhana Memorial Hospital, Thailand
- Government of Colorado
- The Public Health Centre 28 Krung thon buri
- Taksin Hospital
- Sisaket Hospital
- Sanpatong Hospital
- +4 more
Organization Involved with Phase 2 Indications (24)
- Sanofi
- Archivel Farma S.L.
- Biofabri, S.L
- INC Research
- JHP Pharmaceuticals LLC
- Parexel
- Aeras
- National Institute for Medical Research, Tanzania
- National Institute of Allergy and Infectious Diseases (NIAID)
- Cornell University
- Johns Hopkins University
- University of Oslo
- University of Bergen
- Statens Serum Institut
- University of Indonesia
- Aurum Institute
- SATVI
- Badalona Hospital Germans Trias i Pujol
- University of the Witwatersrand
- South African Tuberculosis Vaccine Initiative (SATVI)
- University of Zaragoza
- Stellenbosch University
- TuBerculosis Vaccine Initiative
- National Center for Tuberculosis and Lung Diseases, Georgia
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (6)